WATCH: Capricor Therapeutics – Update on Deramiocel for Cardiomyopathy in Patients with Duchenne (Webinar Recording) ...
The Impact of the Continuing Resolution and Federal Budget Cuts to the CDMRP on Duchenne Research ...
Capricor Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application for Deramiocel ...
Solid Biosciences Shares Initial Data from INSPIRE DUCHENNE Study of Gene Therapy Candidate SGT-003 ...